|Day Low/High||51.50 / 55.15|
|52 Wk Low/High||28.20 / 76.42|
The biotech company plans to commercialize its treatment for AL amyloidosis, a disease that causes protein to build up in the blood.
Karyopharm Therapeutics falls 18%; Lexicon rises on drug approval.
Data Previously Presented in 2015 at 19th International Congress of Parkinson's Disease and Movement Disorders